辛伐他汀干预骨质疏松大鼠骨髓基质细胞后microRNA的差异表达研究
he different expression levels of microRNA in the osteoporotic rat′s bone marrow stromal cell after Simvastatin
目的:探讨在microRNA(miRNA)水平,辛伐他汀促进骨髓基质细胞成骨的可能机制及骨质疏松症发生的可能机制。方法:全骨髓培养法培养离体骨髓基质细胞,骨髓基质细胞扩增至第三代时,细胞分为三个处理组:骨质疏松骨髓基质细胞+辛伐他汀组(OP+SIM)、骨质疏松骨髓基质细胞组(OP+K)、正常骨髓基质细胞组(N+K)。培养第10天时抽提各样本的RNA行miRNA芯片检测,以检测miRNA表达变化水平。结果:miRNA芯片检测:骨质疏松骨髓基质细胞+辛伐他汀组与骨质疏松骨髓基质细胞组相比较,有20种miRNA表达上调,27种miRNA表达下调;骨质疏松骨髓基质细胞组与正常骨髓基质细胞组相比较,有27种miRNA表达上调,另外27种miRNA表达下调。结论:辛伐他汀可能通过直接干预miRNA的表达水平而调节骨髓基质细胞的成骨能力。骨质疏松来源的骨髓基质细胞与正常骨髓基质细胞相比伴有一系列miRNA表达水平的改变。
Objective:This study aims to study the potential mechanisms that how Simvastatin promotes stromal cell in bone marrow to bone and how osteoporosis occurs, according to investigating miRNAs expression. Method: When the whole bone marrow culture method in vitro culture of bone marrow stromal cells, bone marrow stromal cell expansion to the third generation, were divided into three treatment groups: Osteoporosis bone marrow stromal cells plus simvastatin group (OP + SIM), osteoporosis bone marrow stromal cells group (OP + K), normal bone marrow stromal cells group (N + K).To culture day 10 rows miRNA microarray RNA extracted each sample to detect miRNA expression levels.Result: MiRNA microarray assay showed that 20 microRNAs' expression was up-regulated and 27 microRNAs was down-regulated in OP+SIM VS OP+K. In addition, there were 27 microRNAs in up-regulated expression and 27 microRNAs in down-regulated expression in OP+K VS N+K.Conclusion: Simvastatin may direct intervention by the expression levels of miRNA adjusted osteogenic potential of bone marrow stromal cells. Osteoporosis source of bone marrow stromal cells as compared with normal bone marrow stromal cells with a series of miRNA expression levels change
谢福平、陈江
基础医学生物科学研究方法、生物科学研究技术生理学
microRNA骨质疏松骨髓基质细胞辛伐他汀
microRNAosteoporosisbone marrow stromal cellSimvastatin
谢福平,陈江.辛伐他汀干预骨质疏松大鼠骨髓基质细胞后microRNA的差异表达研究[EB/OL].(2016-06-01)[2025-08-24].http://www.paper.edu.cn/releasepaper/content/201606-3.点此复制
评论